AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2010
Mar 5, 2010
32566_dirs_2010-03-05_df3f619a-0f68-4a64-8dcf-34b91dbd5c86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2010-03-03
Reporting Person: Harrison Robert Gardner (Chief Information Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-03-03 | Incentive Stock Option (right to buy) | $23.11 | A | 4328 | Acquired | 2020-03-03 | Common Stock (4328) | Direct |
| 2010-03-03 | Non-Qualified Stock Option (right to buy) | $23.11 | A | 30672 | Acquired | 2020-03-03 | Common Stock (30672) | Direct |
Footnotes
F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2